EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation

Weijie Wu, Wenhai Sui, Sizhe Chen, Ziheng Guo, Xu Jing, Xiaolu Wang, Qun Wang, Xinshuang Yu, Wenjing Xiong, Jiansong Ji, Libo Yang, Yuan Zhang und 9 weitere

Cell Metabolism · 2025-05 · 37 (5) · 1075-1088.e7

DOI: 10.1016/j.cmet.2025.01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2025-05. Verfasst von Weijie Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese …. Hauptthemen laut MEDLINE: Atherosclerosis, Aspartame, Insulin, Sweetening Agents. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Foundation, Vetenskapsrådet, HORIZON EUROPE Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Consumption of artificial sweeteners (ASWs) in various foods and beverages has been linked to an increased risk of cardiovascular diseases (CVDs). However, molecular mechanisms underlying ASW-associated CVD remain unknown. Here, we show that consumption of 0.15% aspartame (APM) markedly increased insulin secretion in mice and monkeys. Bilateral subdiaphragmatic vagotomy (SDV) obliterated APM-elevated blood insulin levels, demonstrating crucial roles of parasympathetic activation in regulation of insulin secretion. Incessant APM feeding of ApoE-/- mice aggravated atherosclerotic plaque formation and growth via an insulin-dependent mechanism. Implantation of an insulin-slow-release pump in ApoE-/- mice exacerbated atherosclerosis. Whole-genome expression profiling discovered that CX3CL1 chemokine was the most upregulated gene in the insulin-stimulated arterial endothelial cells. Specific deletion of a CX3CL1 receptor, Cx3cr1 gene, in monocytes/macrophages completely abrogated the APM-exacerbated atherosclerosis. Our findings uncover a novel mechanism of APM-associated atherosclerosis and therapeutic targeting of the endothelial CX3CL1-macrophage CX3CR1 signaling axis provides an approach for treating atherosclerotic CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisAspartameInsulinSweetening AgentsInflammationAnimalsMiceCX3C Chemokine Receptor 1Mice, Inbred C57BLMaleMacrophagesChemokine CX3CL1Apolipoproteins ESignal TransductionHumansMice, KnockoutPlaque, AtheroscleroticMice, Knockout, ApoE

Stichwörter der Autor:innen

artificial sweeteneraspartameatherosclerosiscardiovascular diseasechemokineinsulininsulin resistancemacrophagestrokevascular inflammation

Substanzen

AspartameInsulinSweetening AgentsCX3C Chemokine Receptor 1Chemokine CX3CL1Apolipoproteins ECx3cr1 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission, Chinese Aca…
  • Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Microbiology, Tumor and Cell Biology, Hong Kong Centre for Cerebro-cardiovascular Health Engineering, Karolinska Institute, 171 65 Stockholm, Sweden.
  • Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, The Central Hospital of Z…
  • Department of Endocrinology, The Affiliated Taian City Central Hospital of Qingdao University, Taian City, Shandong Province, China.
  • Clinical Oncology Department, Weifang People's Hospital, Kuiwen, Weifang, China.

Förderung

  • Novo Nordisk Foundation
  • Vetenskapsrådet
  • HORIZON EUROPE Framework Programme
  • Taishan Scholar Project of Shandong Province
  • Swedish Cancer Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Wu, W., Sui, W., Chen, S., Guo, Z., Jing, X., Wang, X., Wang, Q., Yu, X., Xiong, W., Ji, J., Yang, L., Zhang, Y., Jiang, W., Yu, G., Liu, S., Tao, W., Zhao, C., Zhang, Y., Chen, Y., …, & Cao, Y. (2025). Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation. Cell Metabolism, 37(5), 1075-1088.e7. https://doi.org/10.1016/j.cmet.2025.01.006

Vancouver

Wu W, Sui W, Chen S, Guo Z, Jing X, Wang X, et al. Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation. Cell Metabolism. 2025;37(5):1075-1088.e7. doi:10.1016/j.cmet.2025.01.006

BibTeX
@article{Wu2025,
  author = {Wu, Weijie and Sui, Wenhai and Chen, Sizhe and Guo, Ziheng and Jing, Xu and Wang, Xiaolu and Wang, Qun and Yu, Xinshuang and Xiong, Wenjing and Ji, Jiansong and Yang, Libo and Zhang, Yuan and Jiang, Wenjing and Yu, Guohua and Liu, Shuzhen and Tao, Wei and Zhao, Chen and Zhang, Yun and Chen, Yuguo and Zhang, Cheng and Cao, Yihai},
  title = {Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation},
  journal = {Cell Metabolism},
  year = {2025},
  volume = {37},
  number = {5},
  pages = {1075--1088.e7},
  doi = {10.1016/j.cmet.2025.01.006}
}
Kostenlos starten →